This move aims to enable Zenex to strengthen its portfolio of offerings by adding herbals and furthering the quality of its overall animal health portfolio globally
Zenex, animal health company has announced a 100 per cent acquisition of Ayurvet.
Ayurvet, a company founded by Pradip Burman, is provider of natural ayurvedic and herbal medicines, feed supplements and topical treatments for farm and companion animals.
This move aims to enable Zenex to strengthen its portfolio of offerings by adding herbals and furthering the quality of its overall animal health portfolio globally.
Commenting on the acquisition, Dr Arun Atrey, MD and CEO of Zenex, said, “The acquisition will augment Zenex’s growth, as it operates in a completely complementary space to the Company’s current operations. Further, it will strengthen Zenex’s geographical presence. Ayurvet’s presence in EU (Poland) would aid Zenex Animal Health’s export division to expand its base in the EU region as well. This strategic move aligns with Zenex’s vision to offer an expansive array of high-quality, diverse solutions in the animal health space.”
Renuka Ramnath, Chairperson, Zenex and Founder, MD and CEO, Multiples Alternate Asset Management said, “This acquisition marks an important step to augment our product offering and cement our leadership in India animal healthcare. As part of Zenex’s long-term value creation journey, we will continue to seek interesting opportunities to bring companies with complementary capabilities into our fold, and scale them on the back of Zenex’s entrenched sales and distribution network.”
Pradip Burman, Founder, Ayurvet, said “We are pleased that Ayurvet is being acquired by Zenex, a company with similar commitment to propagating ayurvedic and herbal solutions for animal healthcare, not just for the commercial benefits, but also, for the health benefits these products and solutions bring to animals. We are confident in the management of Zenex, that the vision with which I started Ayurvet, and the legacy built over the past 31 years, will be carried forward.”
- Advertisement -